Neonates need tailored drug formulations

Area of Science:

• Neonatal pharmacology
• Pediatric drug development
• Clinical pharmacy

Background:

• Neonatal intensive care relies on drugs, yet adult formulations are commonly used.
• Existing drug formulations lack tailoring for neonatal physiology and specific needs.
• Specialized equipment for neonates contrasts with the use of non-adapted drug formulations.

Purpose of the Study:

• Advocate for tailored drug formulations for neonates.
• Highlight the need for age-specific active compounds and formulations.
• Emphasize optimizing dosage and excipient exposure in neonatal drug development.

Main Methods:

• Review of current neonatal drug administration practices.
• Analysis of pharmacokinetic and pharmacodynamic considerations in neonates.
• Evaluation of compounding practices for neonatal drug formulations.

Main Results:

• Current adult drug formulations are suboptimal for neonates.
• Neonatal drug development requires consideration of low-dose administration and variability.
• Excipient exposure must be quantified and limited in neonatal formulations.

Conclusions:

• Tailored drug formulations are essential for improving neonatal outcomes.
• Development of specific neonatal drug vials and formulations is crucial.
• Compounding practices must be rigorously evaluated for safety and efficacy until tailored products are available.